GLP-1 drugs
Scope
Date
~
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Earnings
Meritz Securities poised to become Korea’s No. 1 for first time
Meritz Securities Co., once a mid-tier securities firm in South Korea, is expected to command the local market as No. 1 after earning more than 1 tr...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Markets
Kim&Chang sets to enter Indonesia's legal market
Kim & Chang, South Korea's leading law firm, is poised to expand into Indonesia, joining the race among major legal firms seeking a foothold in ...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Korean Air launches development of Korean regional GPS system
South Korea's national flag carrier Korean Air Lines Co. on Tuesday announced the start of its development of the Korean Positioning System (KPS), a...
Feb 01, 2023 (Gmt+09:00)
-
Airlines
South Korea's Jeju Air to open up Indonesian skies
Jeju Air Co. and Indonesia's largest airline corporation will work together to develop flight routes and discover new tourism business opportunities...
Jan 31, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha kickstarts localization of 1,000-hp gas turbine engine components
A project to lengthen the lifecycle of 1,000-horsepower gas turbine engine core components and materials, which is led by Hanwha Aerospace Co. locat...
Jan 31, 2023 (Gmt+09:00)
-
Pension funds
NPS underperforms global peers by returns for Q1-Q3 2022
South Korea's National Pension Service (NPS), the world's third-largest pension fund, ranked 10th out of the global 42 state-owned investors by rate...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Korean startups
A-Team Ventures succeeds in attracting $4.1 mn investment from LX
A-Team Ventures, which runs an online manufacturing platform "Capa," said on Friday that it has raised a Series B funding of 5 billion won ($4.1 mil...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
AgTech
Korean tractor exports hit record high of $1.3 bn in 2022
Exports of South Korean tractors hit a fresh record high for the second consecutive year in 2022, according to Korea Customs Service on Jan. 24. Kor...
Jan 25, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HSD Engine's order volume exceeds $162.1 million in one month
Growth in shipbuilding orders has greatly boosted the sales of manufacturers of related equipment such as ship engines. South Korea's HSD Engine, wh...
Jan 25, 2023 (Gmt+09:00)
-
Healthcare
S-1 unveils AED with analysis time reduced to 2 seconds
S-1 Corp., a security affiliate of South Korea's Samsung Group, has been expanding its presence into the automated external defibrillator (AED) area...
Jan 25, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor sells 1 mn electric vehicles worldwide
In 11 years since Hyundai Motor Group started selling electric vehicles (EVs), the cumulative sales volume of EVs in the global market has finally s...
Jan 25, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
KSOE wins orders for 7 LNG carriers in 1 week
Korea Shipbuilding & Offshore Engineering (KSOE), a mid-level shipbuilding holding affiliate of HD Hyundai Co., has landed successive orders for...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's K-CAB to get insurance benefits in China
South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Electronics
Global smartphone shipments hit 10-year low in 2022
Global smartphone shipments last year declined to their lowest level in 10 years, showing how consumers closed their wallets amid the economic downt...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong accelerates investment in CDMO business
Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...
Jan 18, 2023 (Gmt+09:00)
-
Business & Politics
South Korean companies ink $6.1 billion MOUs with UAE partners
ABU DHABI – Business leaders from South Korea and the United Arab Emirates (UAE) have signed 24 initial agreements worth at least $6.1 billion...
Jan 17, 2023 (Gmt+09:00)
-
IPOs
Korean grocery delivery platform Oasis set for February IPO
South Korean grocery delivery platform Oasis Corp. aims to raise up to $166 million through a listing next month, becoming the country’s first...
Jan 13, 2023 (Gmt+09:00)
Latest News
- 1 BOK chief warns against aggressive policy rate cuts, sees need for fiscal stimulus
- 2 S.Korea eases path for foreign REITs in senior housing push
- 3 Koramco targets $7 bn bets on Korea data centers
- 4 Lotte Chemical, HD Hyundai seek big deal via merger of naphtha cracking facilities
- 5 South Korea accelerates stablecoin framework in global race